Awarded without open competition
Awarded without open competition. The buyer went directly to one or a few suppliers instead of advertising the contract. Procurement rules allow this only in specific cases, such as extreme urgency, when only one supplier can do the work, or for call-offs from an existing framework.
Key facts
- Buyer
- Business Energy and Industrial Strategy · Ministry or any other national or federal authority, including their regional or local subdivisions
- Supplier
- Janssen Pharmaceutica NV
- Value
- £1
- Procedure
- Award procedure without prior publication of a call for competition
- Sector
- Medical equipment & pharmaceuticals · Vaccines (CPV 33651600)
- Region
- London
- Official notice
- 002970-2021 on Find a Tender
- Timeline
-
- Contract date15 Jan 2021
- Published12 Feb 2021Published 28 days after the contract date
Description
This contract has been procured using the negotiated procedure without prior publication under regulation 32 of the Public Contracts Regulations 2015 on the basis that the award of the contract to Janssen is strictly necessary for unforeseeable reasons of extreme urgency; i.e. the urgent requirement to secure priority access to a viable vaccine to end the Covid-19 pandemic (Regulation 32(2)(c)). Additional information: Information on contract value is being withheld due to commercial sensitivity under Regulation 50(6)(b) and (c) as the publication of the price may enable competitors to calculate cost per dose. This will (i) commercially prejudice the supplier in its ongoing negotiations with other national governments; (ii) commercially prejudice the contracting authority in its ongoing negotiations with other vaccine vendors and (iii) impact fair competition between vaccine vendors.
About the supplier
Janssen Pharmaceutica NV: every public contract they have won.